SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-019332
Filing Date
2022-10-06
Accepted
2022-10-06 08:09:11
Documents
13
Period of Report
2022-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K srzn-20220930.htm   iXBRL 8-K 63212
  Complete submission text file 0000950170-22-019332.txt   218321

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srzn-20220930_def.xml EX-101.DEF 13694
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srzn-20220930_pre.xml EX-101.PRE 12994
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srzn-20220930.xsd EX-101.SCH 3109
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srzn-20220930_lab.xml EX-101.LAB 17592
7 EXTRACTED XBRL INSTANCE DOCUMENT srzn-20220930_htm.xml XML 6585
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

IRS No.: 981556622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39635 | Film No.: 221297137
SIC: 2836 Biological Products, (No Diagnostic Substances)